Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

3.41
-0.0600-1.73%
Post-market: 3.440.0300+0.88%19:59 EDT
Volume:8.76M
Turnover:29.47M
Market Cap:1.02B
PE:-6.00
High:3.55
Open:3.50
Low:3.24
Close:3.47
Loading ...

Abcellera Biologics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

TD Cowen Keeps Their Buy Rating on AbCellera Biologics (ABCL)

TIPRANKS
·
28 Feb

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
28 Feb

BRIEF-AbCellera Biologics Files For Mixed Shelf, Size Not Disclosed - SEC Filing

Reuters
·
28 Feb

AbCellera files automatic mixed securities shelf

TIPRANKS
·
28 Feb

Abcellera Biologics Inc Files for Mixed Shelf ; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
28 Feb

AbCellera Biologics Q4 GAAP EPS $(0.12) Beats $(0.15) Estimate, Sales $5.10M Miss $7.58M Estimate

Benzinga
·
28 Feb

AbCellera Biologics Reports 2024 Financial Results and Growth

TIPRANKS
·
28 Feb

BRIEF-AbCellera Q4 Revenue USD 5.1 Million Vs. IBES Estimate USD 7.58 Million

Reuters
·
28 Feb

Abcellera Biologics Inc: Qtrly Shr Loss $0.12

THOMSON REUTERS
·
28 Feb

AbCellera Reports Full Year 2024 Business Results

Business Wire
·
28 Feb

AbCellera Biologics Changes COO's Title to Technology Chief

MT Newswires Live
·
19 Feb

AbCellera COO transitions to Chief Technology Officer

TIPRANKS
·
19 Feb

One AbCellera Biologics Insider Raised Their Stake In The Previous Year

Simply Wall St.
·
18 Feb

AbCellera to Participate at Upcoming Investor Conferences in March

Business Wire
·
12 Feb

AbCellera Biologics On Track For Largest Percent Increase Since August 2022 -- Data Talk

Dow Jones
·
23 Jan

3 Promising US Penny Stocks With Market Caps Under $900M

Simply Wall St.
·
22 Jan

Press Release: AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Dow Jones
·
22 Jan

AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%

Simply Wall St.
·
20 Jan

AbCellera expands collaboration with AbbVie

TipRanks
·
14 Jan